Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantationKURUVILLA, J; FORREST, D. L; LAVOIE, J. C et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 11, pp 969-973, issn 0268-3369, 5 p.Article

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors : long-term resultsRAMADAN, K. M; CONNORS, J. M; FORREST, D. L et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 9, pp 601-608, issn 0268-3369, 8 p.Article

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomesSONG, K. W; BARNETT, M. J; SMITH, C. A et al.Annals of oncology. 2007, Vol 18, Num 3, pp 535-540, issn 0923-7534, 6 p.Article

Shifting to outpatient management of acute myeloid leukemia : a prospective experienceSAVOIE, M. L; NEVIL, T. J; LAVOIE, J. C et al.Annals of oncology. 2006, Vol 17, Num 5, pp 763-768, issn 0923-7534, 6 p.Article

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II studyFORREST, D. L; THOMPSON, K; DORCAS, V. G et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 12, pp 1143-1149, issn 0268-3369, 7 p.Article

Myeloablative allografting for chronic lymphocytic leukemia : evidence for a potent graft-versus-leukemia effect associated with graft-versus-host diseaseTOZE, C. L; GALAL, A; VOSS, N. J et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 9, pp 825-830, issn 0268-3369, 6 p.Article

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisFORREST, D. L; NEVILL, T. J; SUTHERLAND, H. J et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 9, pp 915-923, issn 0268-3369, 9 p.Article

Testicular relapse of acute promyelocytic leukemia after allogeneic BMTFORREST, D. L; DALAL, B. I; NAIMAN, S. C et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 8, pp 689-690, issn 0268-3369Article

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensABOU-MOURAD, Y. R; LAU, B. C; SUTHERLAND, H. J et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 295-302, issn 0268-3369, 8 p.Article

Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantationNEVILL, T. J; FUNG, H. C; NAIMAN, S. C et al.Blood. 1998, Vol 92, Num 6, pp 1910-1917, issn 0006-4971Article

Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7) : Confirmation of eosinophil clonal involvement by fluorescence in situ hybridizationFORREST, D. L; HORSMAN, D. E; JENSEN, C. L et al.Cancer genetics and cytogenetics. 1998, Vol 107, Num 1, pp 65-68, issn 0165-4608Article

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AMLNEVILL, T. J; HOGGE, D. E; SHEPHERD, J. D et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 10, pp 659-666, issn 0268-3369, 8 p.Article

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemiaHALIM, T. Y; SONG, K. W; TOZE, C. L et al.Annals of oncology. 2007, Vol 18, Num 7, pp 1246-1252, issn 0923-7534, 7 p.Article

Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalitiesFORREST, D. L; NEVILL, T. J; SHEPHERD, J. D et al.British journal of haematology. 1998, Vol 103, Num 3, pp 630-638, issn 0007-1048Article